“Pharnext Pleotherapy Approach in Orphan Neuropathies”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya Smale

Xavier Paoli of Pharnext  joined us for World Orphan Drug Congress USA 2015 to present about ‘ Pharnext Pleotherapy Approach in Orphan Neuropathies’ 
Download the presentation now to learn more about:
  • R&D process
  • R&D paradigm: pleotherapy
  • CMT1A: Slow progressive peripheral neuropathy
  • PXT-3003 for the treatment of CMT1A
…and much more!
Get your copy here!
To find out more about how PXT-3003 can aid in the treatment of CMT1A , join us at World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.